Delivery Order SPE2DB20D1051-SPE2DB25FD7EF
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,205.20, is for the delivery of 4,559,799 units of the medication Ondansetron HCL 4 mg tablets. The contract has a firm fixed price and an ultimate completion date of February 2, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4,564,170,461 units of Ondansetron HCl 4 mg tablets. The $13,718.34 contract is a firm fixed-price delivery order with an ultimate completion date of April 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,751.14, is for the delivery of ondansetron ODT 4 mg tablets. This is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,116.51 contract is for the supply of 4,559,438,684 units of Ondansetron HCL 4 mg tablets. The contract has a period of performance through December 22, 2022 and was awarded on December 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,214,940 units of the drug ondansetron ODT 4 mg tablet. The delivery order, valued at $1,883.31, is a firm-fixed-price contract with a completion date of July 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the procurement of 4,560,665 units of Ondansetron HCL 4 mg tablets. The contract has a firm fixed price of $5,962.99 and a period of performance through April 21, 2023. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,116,842 units of the drug Ondansetron ODT 4 mg tablets. The award has a ceiling value of $5,097.98 and an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,091.36, is for the delivery of 4,566,561,598 units of 8 mg Ondansetron HCL tablets. The award has a firm fixed price and an ultimate completion date of November 29, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,336.44, is for the delivery of 4,567,058,891 Ondansetron HCL 4 MG Tablets in quantities of 500 per bottle. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price delivery order. There is no set-aside designation for this contract. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,170.40, is for the delivery of 4 mg Ondansetron HCL tablets to support military healthcare programs. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...